Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the following shareholder has lost his share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on July 12, 2019. Stop Transfer Date- 11 Jul 2019 Folio No - 02130033 Name of Shareholder - JANARDAN DHONDU KARAD Certificate No. - 14336 Distinctive No.- 4360268 - 4360367 No. of Shares - 100 Reason - Lost By Holder Request you to take the same on record as required under the provisions of the said Regulation.
12-07-2019
Bigul

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Announcement under Regulation 30 (LODR)-Newspaper Publication
10-07-2019
Bigul

Novartis India Ltd - 500672 - Reg. 34 (1) Annual Report

 Dear Sirs, Pursuant to Regulation 30 and 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Annual Report of the Company for the Financial Year 2018-19 along with the Notice convening the 71st Annual General Meeting scheduled to be held on August 09, 2019 at 11:30 a.m. at Mumbai Cricket Association [MCA] Banquet Hall, Ground Floor, G Block BKC, RG - 2, Bandra (E), Mumbai 400 051. The same is available on website of the Company i.e. www.novartis.in We request you to take the above information on record. Thanking You.
08-07-2019
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the following shareholder has lost his share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on July 05, 2019. Stop Transfer Date Folio No Name of Shareholder Certificate No. Distinctive No. No. of Shares Reason 04 Jul 2019 02269058 RUTTON PIROSHA NANJI 21078p 15821298 - 15821507 210 Lost By Holder Request you to take the same on record as required under the provisions of the said Regulation. Thanking you
05-07-2019
Bigul

Novartis India introduces 26 weeks of gender-neutral parental leave

 Multinational drugmaker Novartis has introduced a gender-neutral parental policy for its employees in India, in step with what is increasingly becomi
01-07-2019
Bigul

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sirs, In continuation to our letter dated June 26, 2019 please find enclosed copies of Notice of Board Meeting that was published in the Financial Express and Navshakti on June 27, 2019. The Board Meeting of the Company is scheduled to be held on Thursday, August 08, 2019. The same has been made available on the website of the Company www.novartis.in. Thanking you
27-06-2019
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the following shareholder has lost his share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on June 27, 2019. Stop Transfer Date Folio No Name of Shareholder Certificate No. Distinctive No. No. of Shares Reason 26 Jun 2019 02055813 C GEORGE THOMAS 10740 3833267 - 3833386 120 Lost By Holder Request you to take the same on record as required under the provisions of the said Regulation. Thanking you
27-06-2019
Bigul

Novartis India Ltd - 500672 - Board Meeting Intimation for Board Meeting Intimation For Considering; Inter-Alia Unaudited Financial Results Of The Company For The First Quarter Ended June 30, 2019.

 NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2019 ,inter alia, to consider and approve Dear Sirs, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 08, 2019; inter-alia to consider unaudited financial results of the Company for the first quarter ended June 30, 2019. Further, pursuant to the Code of conduct to regulate, monitor and report share trading by Insiders, the trading window for dealing in the securities of the Company would remain closed from July 01, 2019 to August 10, 2019 (both days inclusive). Further, a copy of this notice will be published in the selected newspapers and will be made available on the website of the Company www.novartis.in. This is for your information. Thanking You.
26-06-2019
Bigul

Novartis India Ltd - 500672 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements)Regulations, 2015

 Dear Sirs, Sub: Compliance under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements Regulation, 2015) Pursuant to the Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose disclosure of Related Party Transactions in the format specified in the relevant accounting standards for the half year ended March 31, 2019. Please take the same on record.
21-06-2019
Bigul

Novartis India appoints Sanjay Murdeshwar as managing director and vice chairman

 Currently, Murdeshwar is Novartis' country president in India and is responsible for the company's pharmaceuticals business
15-06-2019
Next Page
Close

Let's Open Free Demat Account